Diagnostic performance of 1,5-anhydroglucitol compared to 2-h glucose in the Atherosclerosis risk in communities study

Bethany Warren; Alexandra K. Lee; Christie M. Ballantyne; Ron C. Hoogeveen; James S. Pankow; Morgan Grams; Anna Köttgen; Elizabeth Selvin

doi:10.1373/clinchem.2018.291773

Diagnostic performance of 1,5-anhydroglucitol compared to 2-h glucose in the Atherosclerosis risk in communities study

Bethany Warren, Alexandra K. Lee, Christie M. Ballantyne, Ron C. Hoogeveen, James S. Pankow, Morgan Grams, Anna Köttgen, Elizabeth Selvin

Epidemiology & Community Health

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1536-1537
Number of pages	2
Journal	Clinical chemistry
Volume	64
Issue number	10
DOIs	https://doi.org/10.1373/clinchem.2018.291773
State	Published - Oct 2018

Bibliographical note

Funding Information:
tyne, Abbott, Roche Diagnostics; R.C. Hoo-geveen, Denka Seiken. Stock Ownership: None declared. Honoraria: None declared. Research Funding: The Atherosclerosis Risk in Communities study is carried out as a collaborative study supported by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Department of Health and Human Services, under the following contracts: HHSN268201700001I, HHSN268201700003I, HHSN268201700 005I, HHSN268201700004I, HHSN2682 01700002I. Reagents for the 1,5-anhydroglucitol assays were donated by GlycoMark, Inc. B. Warren, NIH/NHLBI grant T32 HL007024; A.K. Lee, NIH/NHLBI grant T32 HL007024; E. Selvin, NIH/NIDDK grants K24DK10 6414 and R01DK089174. Expert Testimony: None declared. Patents: C.M. Ballantyne, 61721475.

Publisher link

10.1373/clinchem.2018.291773

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178819

Find It

Find It at U of M Libraries

Cite this

@article{fb475a18e5204625897095ddc9c9f507,

title = "Diagnostic performance of 1,5-anhydroglucitol compared to 2-h glucose in the Atherosclerosis risk in communities study",

author = "Bethany Warren and Lee, {Alexandra K.} and Ballantyne, {Christie M.} and Hoogeveen, {Ron C.} and Pankow, {James S.} and Morgan Grams and Anna K{\"o}ttgen and Elizabeth Selvin",

note = "Funding Information: tyne, Abbott, Roche Diagnostics; R.C. Hoo-geveen, Denka Seiken. Stock Ownership: None declared. Honoraria: None declared. Research Funding: The Atherosclerosis Risk in Communities study is carried out as a collaborative study supported by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Department of Health and Human Services, under the following contracts: HHSN268201700001I, HHSN268201700003I, HHSN268201700 005I, HHSN268201700004I, HHSN2682 01700002I. Reagents for the 1,5-anhydroglucitol assays were donated by GlycoMark, Inc. B. Warren, NIH/NHLBI grant T32 HL007024; A.K. Lee, NIH/NHLBI grant T32 HL007024; E. Selvin, NIH/NIDDK grants K24DK10 6414 and R01DK089174. Expert Testimony: None declared. Patents: C.M. Ballantyne, 61721475.",

year = "2018",

month = oct,

doi = "10.1373/clinchem.2018.291773",

language = "English (US)",

volume = "64",

pages = "1536--1537",

journal = "Clinical Chemistry",

issn = "0009-9147",

publisher = "American Association for Clinical Chemistry Inc.",

number = "10",

}

TY - JOUR

T1 - Diagnostic performance of 1,5-anhydroglucitol compared to 2-h glucose in the Atherosclerosis risk in communities study

AU - Warren, Bethany

AU - Lee, Alexandra K.

AU - Ballantyne, Christie M.

AU - Hoogeveen, Ron C.

AU - Pankow, James S.

AU - Grams, Morgan

AU - Köttgen, Anna

AU - Selvin, Elizabeth

N1 - Funding Information: tyne, Abbott, Roche Diagnostics; R.C. Hoo-geveen, Denka Seiken. Stock Ownership: None declared. Honoraria: None declared. Research Funding: The Atherosclerosis Risk in Communities study is carried out as a collaborative study supported by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Department of Health and Human Services, under the following contracts: HHSN268201700001I, HHSN268201700003I, HHSN268201700 005I, HHSN268201700004I, HHSN2682 01700002I. Reagents for the 1,5-anhydroglucitol assays were donated by GlycoMark, Inc. B. Warren, NIH/NHLBI grant T32 HL007024; A.K. Lee, NIH/NHLBI grant T32 HL007024; E. Selvin, NIH/NIDDK grants K24DK10 6414 and R01DK089174. Expert Testimony: None declared. Patents: C.M. Ballantyne, 61721475.

PY - 2018/10

Y1 - 2018/10

UR - http://www.scopus.com/inward/record.url?scp=85054741933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054741933&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2018.291773

DO - 10.1373/clinchem.2018.291773

M3 - Letter

C2 - 30087139

AN - SCOPUS:85054741933

SN - 0009-9147

VL - 64

SP - 1536

EP - 1537

JO - Clinical Chemistry

JF - Clinical Chemistry

IS - 10

ER -

Diagnostic performance of 1,5-anhydroglucitol compared to 2-h glucose in the Atherosclerosis risk in communities study

Bibliographical note

Publisher link

Find It

Other files and links

Cite this